Literature DB >> 17988702

Protection of macaques against AIDS with a live attenuated SHIV vaccine is of finite duration.

Anil Kumar1, Zhenqian Liu, Darlene Sheffer, Marilyn Smith, Dinesh K Singh, Shilpa Buch, Opendra Narayan.   

Abstract

Using background data that live vaccines against several viral pathogens are effective in inducing life-long protection against disease, we undertook studies in macaques to determine the duration of protection that two live SHIV vaccines could induce against AIDS. Earlier studies had established that macaques immunized once with a live vaccine and challenged 6 months later were protected, and that other macaques given two sequential inoculations of live vaccines were protected for at least 1 year. Protection was associated with persistence of the vaccine viruses. In this study, we sought to determine whether the duration of protection in macaques given a single inoculation of replication competent live vaccines would extend beyond 3 years. Two groups of four rhesus macaques were inoculated with two live SHIV vaccines, respectively. The viruses replicated transiently in all animals but at the 3-year time point, PCR analysis of PBMC did not detect DNA of either virus in any of the animals, and all were negative for CMI responses in the blood. All 8 animals succumbed to disease when challenged with pathogenic viruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988702      PMCID: PMC2757128          DOI: 10.1016/j.virol.2007.10.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

Review 1.  T cell dynamics in HIV-1 infection.

Authors:  Daniel C Douek; Louis J Picker; Richard A Koup
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Systemic infection and limited replication of SHIV vaccine virus in brains of macaques inoculated intracerebrally with infectious viral DNA.

Authors:  Marilyn S Smith; Yafen Niu; Zhuang Li; Istvan Adany; David M Pinson; Zhen Qian Liu; Tanesha Berry; Darlene Sheffer; Fenglan Jia; Opendra Narayan
Journal:  Virology       Date:  2002-09-15       Impact factor: 3.616

Review 3.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.

Authors:  Giuseppe Pantaleo; Richard A Koup
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

4.  Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

Authors:  R P Johnson; R L Glickman; J Q Yang; A Kaur; J T Dion; M J Mulligan; R C Desrosiers
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus.

Authors:  T Igarashi; Y Endo; G Englund; R Sadjadpour; T Matano; C Buckler; A Buckler-White; R Plishka; T Theodore; R Shibata; M Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques.

Authors:  Glenn A Mackay; Yafen Niu; Zhen Qian Liu; Sampa Mukherjee; Zhuang Li; Istvan Adany; Shilpa Buch; Wu Zhuge; Harold M McClure; Opendra Narayan; Marilyn S Smith
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

7.  Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

Authors:  A Kumar; J D Lifson; Z Li; F Jia; S Mukherjee; I Adany; Z Liu; M Piatak; D Sheffer; H M McClure; O Narayan
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

8.  Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.

Authors:  Kristina Abel; Lara Compton; Tracy Rourke; David Montefiori; Ding Lu; Kristina Rothaeusler; Linda Fritts; Kristen Bost; Christopher J Miller
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 9.  Importance and detection of virus reservoirs and compartments of HIV infection.

Authors:  David C Nickle; Daniel Shriner; John E Mittler; Lisa M Frenkel; James I Mullins
Journal:  Curr Opin Microbiol       Date:  2003-08       Impact factor: 7.934

10.  Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.

Authors:  Anil Kumar; Sampa Mukherjee; Jing Shen; Shilpa Buch; Zhuang Li; Istvan Adany; Zhenqian Liu; Wu Zhuge; Michael Piatak; Jeffrey Lifson; Harold McClure; Opendra Narayan
Journal:  Virology       Date:  2002-09-30       Impact factor: 3.616

View more
  6 in total

1.  Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease.

Authors:  Jodi K Craigo; Shannon Barnes; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Vaccine       Date:  2010-10-16       Impact factor: 3.641

2.  Longitudinal study to assess the safety and efficacy of a live-attenuated SHIV vaccine in long term immunized rhesus macaques.

Authors:  Thomas M Yankee; Darlene Sheffer; Zhengian Liu; Sukhbir Dhillon; Fenglan Jia; Yahia Chebloune; Edward B Stephens; Opendra Narayan
Journal:  Virology       Date:  2008-11-05       Impact factor: 3.616

3.  Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.

Authors:  Neil Berry; Claire Ham; Edward T Mee; Nicola J Rose; Giada Mattiuzzo; Adrian Jenkins; Mark Page; William Elsley; Mark Robinson; Deborah Smith; Deborah Ferguson; Greg Towers; Neil Almond; Richard Stebbings
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

4.  Long-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccine.

Authors:  Géraldine Arrode-Brusés; Maha Moussa; Monique Baccard-Longere; François Villinger; Yahia Chebloune
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

5.  Envelope determinants of equine lentiviral vaccine protection.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Liu Chong; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

Review 6.  Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.

Authors:  Aoife K O'Connell; Florian Douam
Journal:  Vaccines (Basel)       Date:  2020-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.